Literature DB >> 20788633

Abnormal Haemoglobins.

.   

Abstract

Year:  1957        PMID: 20788633      PMCID: PMC1974001     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  10 in total

1.  Hyposthenuria in sickle cell anemia: a reversible renal defect.

Authors:  H A ITANO; H G KEITEL; D THOMPSON
Journal:  J Clin Invest       Date:  1956-09       Impact factor: 14.808

2.  Studies on hemoglobin E. I. The clinical, hematologic, and genetic characteristics of the hemoglobin E syndromes.

Authors:  A I CHERNOFF; V MINNICH; S NANAKORN; S TUCHINDA; C KASHEMSANT; R R CHERNOFF
Journal:  J Lab Clin Med       Date:  1956-03

3.  Sicklemia and infarction of the spleen during aerial flight; electrophoresis of the hemoglobin in 15 cases.

Authors:  E W SMITH; C L CONLEY
Journal:  Bull Johns Hopkins Hosp       Date:  1955-01

4.  Haemoglobin E in Indonesia.

Authors: 
Journal:  Nature       Date:  1955-09-03       Impact factor: 49.962

5.  Haemoglobin E in Burmese; two cases of haemoglobin E disease.

Authors:  H LEHMANN; P STORY; H THEIN
Journal:  Br Med J       Date:  1956-03-10

6.  Detection of foetal and sickle-cell haemoglobins in human anaemias.

Authors:  G H BEAVEN; J C WHITE
Journal:  Nature       Date:  1953-11-28       Impact factor: 49.962

7.  The Inheritance of Sickle-Cell Anaemia in Man.

Authors:  W H Taliaferro; J G Huck
Journal:  Genetics       Date:  1923-11       Impact factor: 4.562

8.  Studies on abnormal hemoglobins. I. Their demonstration in sickle cell anemia and other hematologic disorders by means of alkali denaturation.

Authors:  K SINGER; A I CHERNOFF; L SINGER
Journal:  Blood       Date:  1951-05       Impact factor: 22.113

9.  X-ray and solubility studies of the haemoglobin of sickle-cell anaemia patients.

Authors:  R R PERUTZ; A M LIQUORI; F EIRICH
Journal:  Nature       Date:  1951-06-09       Impact factor: 49.962

10.  Sickle cell anemia a molecular disease.

Authors:  L PAULING; H A ITANO
Journal:  Science       Date:  1949-11-25       Impact factor: 47.728

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.